Company Filing History:
2 out of 637 
1 out of 3,684 
1 out of 6 Years Active: 1989-1991
Title: Michael S Eison: Innovator in Brain Treatment Technologies
Introduction
Michael S Eison is a notable inventor based in Avon, Connecticut, who has made significant contributions to the field of medical treatments for brain disorders. With a total of four patents to his name, Eison's work focuses on innovative methods to protect and enhance brain function.
Latest Patents
Eison's latest patents include a groundbreaking method for the treatment of ischemia in the brain. This process aims to protect brain cells from ischemia and treat ischemic and degenerative brain disorders. It involves the systemic administration of BMY 14802 or a pharmaceutically acceptable acid addition salt and/or hydrate. Another notable patent involves THAZ derivatives for the enhancement of cerebral function. These tetrahydro-isoxazolo[4,5-d]azepine derivatives possess antiamnesic properties and serve as cognition enhancers.
Career Highlights
Throughout his career, Eison has worked with prominent companies in the pharmaceutical industry, including Bristol-Myers Company and Bristol-Myers Squibb Company. His experience in these organizations has allowed him to develop and refine his innovative ideas in the realm of brain health.
Collaborations
Eison has collaborated with esteemed colleagues such as Christopher G Boissard and Duncan P Taylor, contributing to the advancement of research and development in his field.
Conclusion
Michael S Eison's contributions to brain treatment technologies highlight his dedication to improving cognitive health through innovative methods. His patents reflect a commitment to advancing medical science and enhancing the quality of life for individuals affected by brain disorders.